发明名称 |
Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
摘要 |
The present invention is directed to 5-HT2 antagonists and their use as agents in the treatment of obsessive-compulsive disorders (OCD). The invention is particularly directed to the compound (+)- alpha -(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol which is a member of a class of 5-HT2 antagonists known as N-aralkyl piperidinemethanol derivatives which are potent and selective inhibitors of the binding of serotonin at the 5-HT2 receptor site.
|
申请公布号 |
US5618824(A) |
申请公布日期 |
1997.04.08 |
申请号 |
US19940209084 |
申请日期 |
1994.03.09 |
申请人 |
MERRELL PHARMACEUTICALS INC. |
发明人 |
SCHMIDT, CHRISTOPHER J.;KEHNE, JOHN H.;PADICH, ROBERT A. |
分类号 |
C07D211/22;A61K31/445;A61K31/451;A61K45/00;A61P43/00;(IPC1-7):A61K31/445 |
主分类号 |
C07D211/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|